Israel - hebraico - Ministry of Health

a.l. medi-market ltd. - azithromycin as dihydrate - אבקה להכנת תמיסה לאינפוזיה - azithromycin as dihydrate 500 mg/vial - azithromycin

Israel - hebraico - Ministry of Health

pfizer pharmaceuticals israel ltd - azithromycin - אבקה להכנת תרחיף - azithromycin 2.096 g - azithromycin - azithromycin - zmax is indicated for the treatment of patients 18 years of age and above with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. adults: acute bacterial sinusitis due to haemophilus influenzae moraxella catarrhalis or streptococcus pneumoniae. community-acquired pneumonia due to chlamydophila pneumoniae, haemophilus influenzae mycoplasma pneumoniae or streptococcus pneumoniae in patients appropriate for oral therapy.

Israel - hebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - azithromycin - אבקה להכנת תרחיף - azithromycin 200 mg / 5 ml - azithromycin - azithromycin - for infections caused by susceptible organisms :in lower respiratory tract infections including bronchitis and pneumonia, in skin and soft tissue infections, in otitis media and in upper respiratory tract infections including sinusitis and pharyngitis tonsillitis. azithromycin teva is also indicated in the treatment of uncomplicated genital infections due to chlamydia trachomatis.

Israel - hebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - azithromycin - אבקה להכנת תרחיף - azithromycin 200 mg / 5 ml - azithromycin - azithromycin - for infections caused by susceptible organisms : in lower respiratory tract infections including bronchitis and pneumonia, in skin and soft tissue infections, in otitis media and in upper respiratory tract infections including sinusitis and pharyngitis tonsillitis. azithromycin teva is also indicated in the treatment of uncomplicated genital infections due to chlamydia trachomatis.

Israel - hebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - azithromycin - אבקה להכנת תרחיף - azithromycin 200 mg / 5 ml - azithromycin

Israel - hebraico - Ministry of Health

gilead sciences israel ltd - bictegravir as sodium; emtricitabine; tenofovir alafenamide as fumarate - טבליות מצופות פילם - tenofovir alafenamide as fumarate 25 mg; emtricitabine 200 mg; bictegravir as sodium 50 mg - emtricitabine, tenofovir alafenamide and bictegravir

Israel - hebraico - Ministry of Health

gilead sciences israel ltd - bictegravir as sodium; emtricitabine; tenofovir alafenamide as fumarate - טבליות מצופות פילם - tenofovir alafenamide as fumarate 25 mg; emtricitabine 200 mg; bictegravir as sodium 50 mg - emtricitabine, tenofovir alafenamide and bictegravir

Israel - hebraico - Ministry of Health

bioavenir ltd, israel - azithromycin as dihydrate - אבקה להכנת תמיסה מרוכזת לעירוי - azithromycin as dihydrate 500 mg/vial - azithromycin

Israel - hebraico - Ministry of Health

mbi pharma ltd., israel - azithromycin as dihydrate - אבקה להכנת תמיסה לאינפוזיה - azithromycin as dihydrate 500 mg - azithromycin

Israel - hebraico - Ministry of Health

dexcel ltd, israel - clarithromycin - קפליות - clarithromycin 250 mg - clarithromycin - clarithromycin - klaridex is indicated in the treatment of infections caused by one or more susceptible organisms. indications include: lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia. upper respiratory tract infections, for example, sinusitis and pharyngitis. klaridex is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section. klaridex is also indicated in skin and soft tissue infections of mild to moderate severity. klaridex is also indicated in combination with proton pump inhibitor for the eradication of h. pylori in patients with proven duodenal ulcer. treatment of mycobacterium avium complex infection in aids patients.